$HCM
HUTCHMED (China) Ltd
Nasdaq · Healthcare · Pharmaceutical Preparations · Hong Kong
HCM chart
What traders are saying about $HCM
Latest postsHUTCHMED (China) Ltd news
- RCS - Hutchmed China Ltd - HUTCHMED to Host Event on Recent Savolitinib Data
TradingView ·
- Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
Yahoo Finance ·
- Experts will discuss new data from a lung cancer drug trial
Stock Titan ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- RCS - Hutchmed China Ltd - SANOVO Phase III Data at ESMO
TradingView ·
- HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
Yahoo Finance ·
- A lung cancer drug combination delayed worsening or death for a median 24.9 months
Stock Titan ·
- HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
Yahoo Finance ·
- What HUTCHMED (China) (AIM:HCM)'s GSK Licensing Deal Means For Shareholders
Yahoo Finance ·
- HUTCHMED (China) (AIM:HCM) Closes GSK Licensing Deal, Is It A Bargain Or Fully Priced?
Simply Wall Street ·
- 3 British Healthcare Stocks To Own In October 2026
Yahoo Finance ·
- HUTCHMED (China) Limited Estimates – HKEX:13
TradingView ·
HUTCHMED (China) Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $548.5M | $630.2M | $838.0M | $426.4M |
| Net income | $456.9M | $37.7M | $100.8M | -$360.8M |
| Diluted EPS | $0.52 | $0.04 | $0.12 | $-0.43 |
| Total assets (year end) | $1.75B | $1.27B | $1.28B | $1.03B |
| Cash and equivalents (year end) | $71.3M | $154.0M | $283.6M | $313.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About HUTCHMED (China) Ltd
- Ticker
- HCM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hong Kong
- Incorporated in
- Cayman Islands
- SEC CIK
- 1648257
- Former names
- Hutchison China MediTech Ltd
Frequently asked questions
What exchange is HUTCHMED (China) Ltd listed on?
HUTCHMED (China) Ltd trades on the Nasdaq under the ticker symbol HCM.
What industry is HUTCHMED (China) Ltd in?
HUTCHMED (China) Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is HUTCHMED (China) Ltd headquartered?
HUTCHMED (China) Ltd's business address on file with the SEC is in Hong Kong.
How much revenue did HUTCHMED (China) Ltd report?
HUTCHMED (China) Ltd reported $548.5M in revenue for calendar year 2025, according to its SEC filings.